In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision
Treating the high histamine levels resulted in decreasing levels of specific migraine-related neurotransmitters.[ref] Histamine and Alcohol Genotype Report Access this content: An active subscription is required to access this content
In short, the difference between oral supplementation and injection is that an injection will provide a higher dose of B12 at regular intervals, whilst oral supplements have a lower dosage and can be taken every day
This isnt practical for individuals who suffer from chronic B12 deficiency or frequently deplete the entirety of their B12 stores
adults over 60 have a true B12 deficiency, and roughly 20% have marginal B12 status, according to research published in the American Journal of Clinical Nutrition